AstraZeneca is a global, science-led pharmaceutical company formed in 1999 through the merger of Swedish company Astra AB and British firm Zeneca Group PLC. The merger was completed on April 6, 1999, and the company held its first official day of operations just 40 working days later.[1] The new entity required a unified visual identity to represent the combined business, and the resulting logo has remained largely consistent since its launch.
Design and History
The AstraZeneca logo was created by the branding agency Interbrand Newell & Sorrell and unveiled in June 1999.[2][3] The mark is a stylized joining of the letters “A” and “Z”, placed at the end of the corporate name.[1] The design combines the two letters with the familiar DNA spiral, an attempt to convey the nature of the company’s business in the scientific field.[2][4]
The identity was designed “to reflect the characteristics of our company” according to statements at the time of launch.[3] It was intended that the logo would eventually achieve sufficient recognition that it could be used alone, without the full company name.[3]
Approximately ten years after the original launch, Interbrand was commissioned to refresh the identity, with signage guidelines updated and implemented globally.[5] The logo’s core design has remained essentially unchanged since its inception, with the intent that it would endure and reflect values of scientific rigour, research and innovation.[6]
Meaning and Symbolism
The AstraZeneca symbol merges the letters A and Z with a DNA spiral, directly referencing the company’s scientific and pharmaceutical focus.[2] The modified double helix next to the company name provides an immediate clue that the company operates in the scientific field.[4] The mark has also been described as vaguely resembling a molecular compound, with the letters A and Z emerging from the shape.[7]
Typography and Design
The corporate colours of AstraZeneca were established as purple and gold at the time of the 1999 identity launch, with Helvetica chosen as the typeface for the wordmark.[3] The colour combination was described as “terracotta on purple”, reportedly chosen as softer and more “human” than the hard blues and greens used by many pharmaceutical companies.[2]
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
